Fair Value Calculator Fair Value Calculator
EN DE

RESGEN (RESGEN) Fair Value & Analysis

IN · Market cap ₹999M

R RESGEN RESGEN · BSE
Price₹47.62
Fair Value₹82.51
Upside+73.3%
Quality50/100
Watch RESGEN for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹44.64 – ₹103.49

Fair value as of: Jul 5, 2026

From 24 valuation models · updated today

Share price −13.5% over the past month.

Price vs Fair Value (12 months)

₹94.29 ₹47.62 Fair Value ₹82.51 Jul 2025 Jul 2026

12‑month range ₹47.62 – ₹94.29 · fair‑value band ₹44.64 – ₹103.49 · the ₹47.62 price screens below the ₹82.51 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

RESGEN (RESGEN) currently trades at ₹47.62, while our model-based Fair Value estimate is ₹82.51 — implying the stock looks roughly 73.3% undervalued today. We read business quality at 50/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, RESGEN generated revenue of ₹727M at a net margin of 12.1%. Revenue grew 76.6% year over year. It earns a return on equity of 14.0%. Net debt stands at ₹29.0M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹44.64 (bear case) to ₹103.49 (bull case); at ₹47.62, the current price sits within that range. The share trades about 52% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹727M
Revenue growth (YoY) +76.6%
Net margin 12.1%
Return on equity 14.0%
Free cash flow ₹39.0M FY2026
P/E ratio 9.8
More key figures
Operating margin 20.0%
EPS (TTM) ₹4.86
EPS growth (YoY) +199%
Net debt ₹29.0M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

RESGEN reported revenue of ₹711M in FY2026 versus ₹48.1M in FY2022, a compound +96.1%/yr. Reported net income was ₹87.7M in FY2026, compounding +84.5%/yr from FY2022.

Revenue +96.1%/yr
FY22 ₹48.1M
FY23 ₹235M
FY24 ₹455M
FY25 ₹652M
FY26 ₹711M
Net income +84.5%/yr
FY22 ₹7.6M
FY23 ₹41.7M
FY24 ₹65.7M
FY25 ₹79.8M
FY26 ₹87.7M

Is RESGEN fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "RESGEN Fair Value". https://www.fairvalue-calculator.com/stock/RESGEN

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is RESGEN (RESGEN) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹82.51 versus a price of ₹47.62 — about +73% (undervalued). Model-based estimate, not financial advice.
What is the fair value of RESGEN?
Our model-based fair value for RESGEN is ₹82.51 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹47.62.
What is the quality score of RESGEN?
RESGEN has a Quality Score of 50/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of RESGEN (RESGEN)?
RESGEN reported trailing-twelve-month revenue of about ₹727M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of RESGEN?
The net profit margin of RESGEN is about 12.1%, meaning it keeps roughly 12.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.